Published in Antimicrob Agents Chemother on October 01, 1979
Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia. Antimicrob Agents Chemother (1982) 7.11
Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853. Antimicrob Agents Chemother (1979) 2.21
Quantitative susceptibility test methods in major United States medical centers. Antimicrob Agents Chemother (1981) 1.70
Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials. Nanomedicine (2009) 1.00
Stably integrated luxCDABE for assessment of Salmonella invasion kinetics. Mol Imaging (2009) 0.88
Effect of calcium, magnesium, and zinc on ticarcillin and tobramycin alone and in combination against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1982) 0.85
Evaluation of Petrifilm Select E. coli Count Plate medium to discriminate antimicrobial resistant Escherichia coli. Acta Vet Scand (2008) 0.80
Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis (1974) 7.65
Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin. J Clin Pathol (1969) 5.51
Evaluation of a dispensing instrument (Dynatech MIC-2000) for preparing microtiter antibiotic plates and testing their potency during storage. Antimicrob Agents Chemother (1978) 4.37
Site of action of polymyxin on Pseudomonas aeruginosa: antagonism by cations. J Gen Microbiol (1954) 3.82
Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin. J Infect Dis (1971) 3.76
Activity of aminoglycoside antibiotics aganst Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism. J Infect Dis (1973) 3.67
The mutual effects of antimicrobial compounds and metallic cations. Bacteriol Rev (1957) 3.65
Effect of the concentrations of magnesium and calcium on the in-vitro susceptibility of Pseudomonas aeruginosa to gentamicin. J Infect Dis (1971) 3.41
Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin polymyxin B, and carbenicillin. Antimicrob Agents Chemother (1975) 3.32
Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa. J Infect Dis (1978) 3.29
In vitro studies of tobramycin, an aminoglycoside antibiotic. Antimicrob Agents Chemother (1972) 3.23
Reversal of the antibacterial activity of polymyxin by divalent cations. Nature (1953) 2.68
The Influence of Certain Substances on the Activity of Streptomycin: III. Differential Effects of Various Electrolytes on the Action of Streptomycin. J Bacteriol (1948) 2.66
Influence of serum and calcium on the bactericidal activity of gentamicin and carbenicillin on Pseudomonas aeruginosa. Appl Microbiol (1972) 1.79
Antagonistic effect of calcium in serum on the activity of tobramycin against Pseudomonas. Antimicrob Agents Chemother (1972) 1.67
Locus of divalent cation inhibition of the bactericidal action of polymyxin B. Antimicrob Agents Chemother (1972) 1.65
Role of ionic strength in salt antagonism of aminoglycoside action on Escherichia coli and Pseudomonas aeruginosa. J Infect Dis (1976) 1.22
Effects of divalent cations on binding of aminoglycoside antibiotics to human serum proteins and to bacteria. Antimicrob Agents Chemother (1975) 1.14
In vitro activity of ciprofloxacin (Bay o 9867). Antimicrob Agents Chemother (1983) 6.29
In vitro activity of LY127935. Antimicrob Agents Chemother (1979) 3.88
In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev Infect Dis (1981) 3.32
In vitro activity of LY146032 against staphylococci, streptococci, and enterococci. Antimicrob Agents Chemother (1986) 3.21
Microdilution technique for antimicrobial susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1975) 2.83
Modified microdilution susceptibility test for staphylococci, streptococci and Haemophilus spp. Eur J Clin Microbiol (1984) 2.45
Central nervous system disease associated with Mycoplasma pneumoniae infection. Arch Intern Med (1972) 2.29
Interaction of clindamycin and gentamicin in vitro. Antimicrob Agents Chemother (1974) 2.23
Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853. Antimicrob Agents Chemother (1979) 2.21
Clinical evaluation of cephradine, a new oral cephalosporin. Am J Med Sci (1974) 2.07
Clindamycin in the treatment of serious anaerobic infections. Ann Intern Med (1973) 1.94
Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS (1993) 1.87
Clindamycin: clinical and laboratory evaluation of parenteral therapy. Am J Med Sci (1972) 1.82
In vitro susceptibilities of four species of coagulase-negative staphylococci. Antimicrob Agents Chemother (1986) 1.80
Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group. Clin Infect Dis (2000) 1.73
Rapid identification of nonfermentative gram-negative rods by the Corning N/F system. J Clin Microbiol (1979) 1.72
Revised interpretation of oxacillin MICs for Staphylococcus epidermidis based on mecA detection. Antimicrob Agents Chemother (1995) 1.64
In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophila. Antimicrob Agents Chemother (1980) 1.61
5-fluorocytosine in the treatment of cryptococcal and candida mycoses. Ann Intern Med (1971) 1.61
Central nervous system toxicity associated with metronidazole therapy. Ann Intern Med (1980) 1.54
In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents. Antimicrob Agents Chemother (1981) 1.53
Neuropsychological performance in asymptomatic HIV infection. J Neuropsychiatry Clin Neurosci (1992) 1.52
Comparison of ticarcillin and carbenicillin activity against random and select populations Pseudomonas aeruginosa. Antimicrob Agents Chemother (1978) 1.51
In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs. Arch Intern Med (1980) 1.46
In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli. Antimicrob Agents Chemother (1996) 1.45
Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks. J Clin Microbiol (1985) 1.38
Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles. Clin Infect Dis (1995) 1.24
In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporins. Antimicrob Agents Chemother (1986) 1.22
Antibiotic-impregnated cement and beads for orthopedic infections. Antimicrob Agents Chemother (1996) 1.22
The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3. J Acquir Immune Defic Syndr (1994) 1.22
Positive direct Coombs' tests associated with cephaloridine therapy. JAMA (1970) 1.20
Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients. J Infect Dis (1978) 1.19
Penicillinase production and in vitro susceptibilities of Staphylococcus lugdunensis. Antimicrob Agents Chemother (1990) 1.19
The quinolones. Ann Intern Med (1985) 1.13
Treatment of mixed bacterial infections with clindamycin and gentamicin. J Infect Dis (1977) 1.10
Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults. AIDS (2001) 1.08
Comparative in vitro activities of third-generation cephalosporins. Arch Intern Med (1983) 1.08
Activity of mecillinam alone and in combination with other beta-lactam antibiotics. Antimicrob Agents Chemother (1980) 1.07
Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus. Antimicrob Agents Chemother (1990) 1.07
Psychopathology in human immunodeficiency virus infection: lifetime and current assessment. Compr Psychiatry (1993) 1.06
Letter: Acute meningitis due to a Pseudomonas-like Group Va-1 bacillus. Ann Intern Med (1976) 1.05
Comparative in vitro activities of beta-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli. Antimicrob Agents Chemother (1982) 1.03
Proposed ticarcillin disk control values for Escherichia coli and Pseudomonas aeruginosa: multicenter cooperative study. Antimicrob Agents Chemother (1978) 1.03
Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital. J Antimicrob Chemother (1995) 1.02
A comparison of the effects of mezlocillin and carbenicillin on haemostasis in volunteers. J Antimicrob Chemother (1983) 1.01
Social support and unsupportive social interactions: their association with depression among people living with HIV. AIDS Care (1999) 1.01
Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas species. Antimicrob Agents Chemother (1981) 1.00
Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections. Am J Med (1987) 1.00
Morphology and ultrastructure of staphylococcal L colonies: light, scanning, and transmission electron microscopy. J Bacteriol (1973) 0.99
Correlation of in vitro activities of cephalothin and ceftazidime with their efficacies in the treatment of Staphylococcus aureus endocarditis in rabbits. Antimicrob Agents Chemother (1984) 0.98
Cephalexin--a new oral cephalosporin: clinical evaluation in sixty-three patients. Am J Med Sci (1970) 0.98
In vitro activity of carumonam. Antimicrob Agents Chemother (1985) 0.98
Treatment of skin and soft tissue infections with oral ciprofloxacin. J Antimicrob Chemother (1986) 0.98
Statistical comparison of the antibacterial activities of broad-spectrum penicillins against gram-negative bacilli. Antimicrob Agents Chemother (1983) 0.97
Urinary tract infection. Practical aspects of diagnosis and treatment. JAMA (1973) 0.97
Restriction endonuclease analysis of clinical Pseudomonas aeruginosa strains: useful epidemiologic data from a simple and rapid method. J Clin Microbiol (1993) 0.96
Laboratory tests for defining bactericidal activity as predictors of antibiotic efficacy in the treatment of endocarditis due to Staphylococcus aureus in rabbits. J Infect Dis (1984) 0.96
Platelet-mediated bleeding caused by broad-spectrum penicillins. J Infect Dis (1987) 0.93
Biotypes of serologically nontypable Haemophilus influenzae isolated from the middle ears and nasopharynges of patients with otitis media with effusion. J Clin Microbiol (1984) 0.93
Simplified method for antimicrobial susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1975) 0.92
Treatment of osteomyelitis and septic arthritis with cefazolin. Antimicrob Agents Chemother (1978) 0.92
Clindamycin and gentamicin for aerobic and anaerobic sepsis. Arch Intern Med (1977) 0.91
Depression and neuropsychological performance in asymptomatic HIV infection. Am J Psychiatry (1993) 0.91
Clindamycin and primaquine as primary treatment for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS. Eur J Clin Microbiol Infect Dis (1991) 0.89
Treatment of skin and soft tissue infections with imipenem/cilastatin. Am J Med (1985) 0.89
Chronic meningococcemia. Possible pathogenic role of IgM deficiency. Arch Intern Med (1972) 0.88
Campylobacter fetus sepsis with mycotic aortic aneurysm. Arch Pathol Lab Med (1979) 0.87
Pneumonia and empyema caused by Clostridium sordellii. Am J Med Sci (1978) 0.86
Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections. Antimicrob Agents Chemother (1987) 0.84
Comparative efficacies of mezlocillin and ampicillin alone or in combination with gentamicin in the treatment of Streptococcus faecalis endocarditis in rabbits. Antimicrob Agents Chemother (1984) 0.84
Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection. J Clin Exp Neuropsychol (1994) 0.83
In vitro activity of DNA gyrase inhibitors, singly and in combination, against Mycobacterium avium complex. Diagn Microbiol Infect Dis (1992) 0.83
Report of a case of bacterial sepsis caused by a naturally occurring variant form of Staphylococcus aureus. J Infect Dis (1978) 0.83
Minimal inhibitory concentrations of broad spectrum beta-lactam antibiotics for bacterial control strains. Diagn Microbiol Infect Dis (1983) 0.83
Regression-line analysis of trimethoprim-sulfamethoxazole activity against Neisseria gonorrhoeae. Am J Clin Pathol (1976) 0.82
In vitro activity of cefpiramide (SM-1652) against gram-negative bacilli. Diagn Microbiol Infect Dis (1986) 0.82
Light and scanning-beam electron microscopy of wall-defective Staphylococcus aureus induced by lysostaphin. Infect Immun (1971) 0.82
Drug and alcohol use and neuropsychological performance in asymptomatic HIV infection. J Neuropsychiatry Clin Neurosci (1993) 0.81
In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species. Antimicrob Agents Chemother (1982) 0.81
In vitro activity of RO 23-6240 (AM-833): a new fluoroquinolone. Diagn Microbiol Infect Dis (1987) 0.81
Change in neuropsychological performance in asymptomatic HIV infection: 1-year follow-up. AIDS (1993) 0.80
Duration of illness and neuropsychological performance in asymptomatic HIV infection. J Neuropsychiatry Clin Neurosci (1994) 0.80
Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044. Clin Infect Dis (1994) 0.80
Comparative in vitro activities of apalcillin and piperacillin against gram-negative bacilli. Antimicrob Agents Chemother (1984) 0.80
Quantitation of antigen-specific immune responses in human immunodeficiency virus (HIV)-infected individuals by limiting dilution analysis. J Clin Immunol (1992) 0.79
Light, scanning, and transmission electron microscopy of stable staphylococcal L-forms. Ann N Y Acad Sci (1974) 0.79
Pharmacokinetics and tolerance of a single twelve-tablet dose of trimethoprim (960 mg)-sulfamethoxazole (4,800 mg). Antimicrob Agents Chemother (1977) 0.79
A single large dose of trimethoprim-sulfamethoxazole fails to cure gonococcal urethritis in men. Sex Transm Dis (1999) 0.79
Comparison of antimicrobial in vitro activities against Streptococcus pneumoniae independent of MIC susceptibility breakpoints using MIC frequency distribution curves, scattergrams and linear regression analyses. J Antimicrob Chemother (2001) 0.78
Sexual transmission of viral hepatitis? JAMA (1974) 0.78
Comparative efficacy of prophylactic cephalothin and cefamandole for elective colon surgery: results of a prospective, randomized, double-blind study. Am J Surg (1979) 0.78